Soong W J, Jeng M J, Hwang B
Medical School of National Yang-Ming University, Children's Medical Center, Veterans General Hospital-Taipei, Taiwan, Republic of China.
Intensive Care Med. 1995 Sep;21(9):759-65. doi: 10.1007/BF01704744.
To evaluate the feasibility and effectiveness of 3 different types of silastic catheters that were used for percutaneous central venous catheterization (PCVC) through peripheral veins.
The study was prospective and consecutive for 6 years at a pediatric/neonatal intensive care unit and pediatric ward in Veterans General Hospital-Taipei, a university-affiliated medical center, in Taiwan, ROC.
The patients who had PCVC were consecutively enrolled from January 1988 to December 1993. Three types of silastic catheters were used. The classification was according to the caliber as small catheter (SC, 0.30 mm ID), mid-size catheter (MC, 0.51 mm ID) and large catheter (LC, 0.64 mm ID). The same insertion technique, catheter-through-needle, was used for all PCVC placements through the peripheral vein. After insertion, each catheter was connected to a conventional short cannula (24-, 22-, or 20-gauge) of compatible caliber, and then linked to the infusion system.
1318 PCVCs were used in 1126 consecutive patients, that included 754 SCs in 649 infants (among them 60.9% were less than 1500 g), 383 MCs in 319 toddlers, and 181 LCs in 158 children. Mean (SD) body weight at the time of catheter insertion was SC 1.7(0.9)kg, MC 12.1(6.5)kg and LC 19.3(7.6)kg. Overall, mean (SD) duration of these PCVC was 16.4(8.4) days. A significantly longer duration was noted in: (a) SC group with 19.7(10.4) days than the other two groups [MC 12.4(6.5) days, LC 11.2(5.0) days]; (b) patients with body weight equal to or less than 3.0 kg [18.7(8.6) versus 14.1(6.1); and (c) insertion sites other than external jugular vein (EJV) [18.8(9.7) versus 11.7(6.0)]. These PCVCs provided reliable venous access for multiple purposes such as hyperalimentation, venous access or sampling of blood, antibiotic therapy and chemotherapy. MC and LC were also used for monitoring the central venous pressure. Most of the time, SC and MC were inserted through the superficial peripheral vein of the scalp, neck and extremities, while LC was almost approached via the EJV. The overall success rate of insertion was 92.4% (1318/1427). No significant difference was observed among the different catheter groups [93.4% (754/807) in SC, 90.5% (383/423) in MC and 91.9% (181/197) in LC] and the different insertion sites. Within each group of PCVC, more than eighty percent of catheters were removed electively: 83.3% in SC, 89.6% in MC and 84.5% in LC. Probable catheter-related sepsis accounted for 2.7% (36/1, 318) of all PCVCs. With this study, the cost of each PCVC set is 3.0 US dollar.
This study indicates that the use of three different calibers of silastic catheter is feasible and effective for PCVC in pediatric practice.
评估3种不同类型的硅橡胶导管经外周静脉进行经皮中心静脉置管(PCVC)的可行性和有效性。
本研究为前瞻性连续研究,在台湾地区台北荣民总医院(一所大学附属医院)的儿科/新生儿重症监护病房及儿科病房进行,为期6年。
1988年1月至1993年12月连续纳入接受PCVC的患者。使用了3种类型的硅橡胶导管。根据管径分类为小导管(SC,内径0.30mm)、中号导管(MC,内径0.51mm)和大导管(LC,内径0.64mm)。所有经外周静脉的PCVC置管均采用相同的穿刺技术——导管针穿刺法。置管后,将每根导管连接到管径适配的传统短套管(24号、22号或20号),然后与输液系统相连。
1126例连续患者共进行了1318次PCVC置管,其中649例婴儿置入754根SC导管(其中60.9%体重小于1500g),319例幼儿置入383根MC导管,158例儿童置入181根LC导管。置管时平均(标准差)体重,SC组为1.7(0.9)kg,MC组为12.1(6.5)kg,LC组为19.3(7.6)kg。总体而言,这些PCVC的平均(标准差)留置时间为16.4(8.4)天。观察到以下情况留置时间显著更长:(a)SC组为19.7(10.4)天,长于其他两组[MC组为12.4(6.5)天,LC组为11.2(5.0)天];(b)体重等于或小于3.0kg的患者[18.7(8.6)天对14.1(6.1)天];(c)除颈外静脉(EJV)外的置管部位[18.8(9.7)天对11.7(6.0)天]。这些PCVC为多种目的提供了可靠的静脉通路,如胃肠外营养、静脉通路建立或采血、抗生素治疗及化疗。MC和LC还用于监测中心静脉压。大多数情况下,SC和MC经头皮、颈部及四肢的外周浅静脉置入,而LC几乎均经EJV置入。总体置管成功率为92.4%(1318/1427)。不同导管组[SC组为93.4%(754/807),MC组为90.5%(383/423),LC组为91.9%(181/197)]及不同置管部位之间未观察到显著差异。在每组PCVC中,超过80%的导管为择期拔除:SC组为83.3%,MC组为89.6%,LC组为84.5%。可能与导管相关的败血症占所有PCVC置管的2.7%(36/1318)。本研究中,每套PCVC的成本为3.0美元。
本研究表明,3种不同管径的硅橡胶导管用于儿科PCVC是可行且有效的。